These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 34425840)

  • 1. The impact of LncRNA dysregulation on clinicopathology and survival of pancreatic cancer: a systematic review and meta-analysis (PRISMA compliant).
    Seyed Hosseini E; Nikkhah A; Sotudeh A; Alizadeh Zarei M; Izadpanah F; Nikzad H; Haddad Kashani H
    Cancer Cell Int; 2021 Aug; 21(1):447. PubMed ID: 34425840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of altered long noncoding RNAs in overall survival of ovarian cancer: A systematic review and meta-analysis.
    Seyed Hosseini E; Alizadeh Zarei M; Haddad Kashani H; Milajerdi A; Zare Dehghanani Z; Hassani Bafrani H; Nikzad H
    Pathol Res Pract; 2021 Mar; 219():153363. PubMed ID: 33621920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Impact of lncRNA Dysregulation on Clinicopathology and Survival of Breast Cancer: A Systematic Review and Meta-analysis.
    Tian T; Wang M; Lin S; Guo Y; Dai Z; Liu K; Yang P; Dai C; Zhu Y; Zheng Y; Xu P; Zhu W; Dai Z
    Mol Ther Nucleic Acids; 2018 Sep; 12():359-369. PubMed ID: 30195774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered long noncoding RNAs and survival outcomes in ovarian cancer: A systematic review and meta-analysis (PRISMA Compliant).
    Ning L; Hu YC; Wang S; Lang JH
    Medicine (Baltimore); 2018 Aug; 97(32):e11481. PubMed ID: 30095613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormally expressed lncRNAs in the prognosis and clinicopathology of oesophageal cancer: a systematic review and meta-analysis.
    Qian P; Xu Z; Chen H; Yue S; Lv Y
    J Genet; 2020; 99():. PubMed ID: 32529986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The diagnostic and prognostic value of exosome-derived long non-coding RNAs in cancer patients: a meta-analysis.
    Mu H; Zhang S; Yao Z; Liu Y; Lin K; Zhao Z; Zhu Y
    Clin Exp Med; 2020 Aug; 20(3):339-348. PubMed ID: 32504320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Value of Dysregulated LncRNAs on Clinicopathology and Survival in Non-Small-Cell Lung
    Wang J; Han X; Yuan Y; Gu H; Liao X; Jiang M
    Front Genet; 2022; 13():821675. PubMed ID: 35450214
    [No Abstract]   [Full Text] [Related]  

  • 8. The prognostic value of long non coding RNAs in cervical cancer: A meta-analysis.
    Cui X; Jing X; Wu X
    Oncotarget; 2017 Sep; 8(37):62470-62477. PubMed ID: 28977961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of abnormally expressed lncRNAs in ovarian carcinoma: a systematic review and meta-analysis.
    Luo P; Liu XF; Wang YC; Li ND; Liao SJ; Yu MX; Liang CZ; Tu JC
    Oncotarget; 2017 Apr; 8(14):23927-23936. PubMed ID: 28118613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. lncRNAs as potential molecular biomarkers for the clinicopathology and prognosis of glioma: A systematic review and meta-analysis.
    Zhou Q; Liu J; Quan J; Liu W; Tan H; Li W
    Gene; 2018 Aug; 668():77-86. PubMed ID: 29777909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Values of Long Non-coding RNAs in Bladder Cancer: A Systematic Review.
    Su G; He Q; Wang J
    Front Physiol; 2018; 9():652. PubMed ID: 29899709
    [No Abstract]   [Full Text] [Related]  

  • 12. Meta-analysis of the prognostic value of abnormally expressed lncRNAs in hepatocellular carcinoma.
    Qu Z; Yuan CH; Yin CQ; Guan Q; Chen H; Wang FB
    Onco Targets Ther; 2016; 9():5143-52. PubMed ID: 27574455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological and prognostic value of SNHG6 in cancers: a systematic review and a meta-analysis.
    Zhang S; Qiu D; Xie X; Shen Y
    BMC Cancer; 2020 Apr; 20(1):343. PubMed ID: 32321469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNAs as novel predictors of survival in human cancer: a systematic review and meta-analysis.
    Serghiou S; Kyriakopoulou A; Ioannidis JP
    Mol Cancer; 2016 Jun; 15(1):50. PubMed ID: 27352941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNAs in bladder cancer prognosis: A meta-analysis.
    Zhu W; Liu H; Wang X; Lu J; Yang W
    Pathol Res Pract; 2019 Jun; 215(6):152429. PubMed ID: 31064722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of the long noncoding RNAs in nasopharyngeal carcinoma: a systematic review and meta-analysis.
    Guo H; Huang S; Li S; Yu H; Wu S; Zhou X
    Cancer Manag Res; 2018; 10():1763-1779. PubMed ID: 29988744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. lncRNAs as prognostic molecular biomarkers in hepatocellular carcinoma: a systematic review and meta-analysis.
    Zheng C; Liu X; Chen L; Xu Z; Shao J
    Oncotarget; 2017 Aug; 8(35):59638-59647. PubMed ID: 28938667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNAs as Theragnostic Biomarkers for Predicting Radioresistance in Cancer: A Systematic Review and Meta-Analysis.
    Lin P; Xing W; Ren Q; Wang Q; Yan J; Mao G
    Front Oncol; 2022; 12():767750. PubMed ID: 35692742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormally expressed long non-coding RNAs in prognosis of Osteosarcoma: A systematic review and meta-analysis.
    Chen D; Wang H; Zhang M; Jiang S; Zhou C; Fang B; Chen P
    J Bone Oncol; 2018 Nov; 13():76-90. PubMed ID: 30591861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic and diagnostic values of non-coding RNAs as biomarkers for breast cancer: An umbrella review and pan-cancer analysis.
    Bahramy A; Zafari N; Rajabi F; Aghakhani A; Jayedi A; Khaboushan AS; Zolbin MM; Yekaninejad MS
    Front Mol Biosci; 2023; 10():1096524. PubMed ID: 36726376
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.